Home › Compare › VPTDF vs JNJ

VPTDF vs JNJ: Dividend Comparison 2026

VPTDF yields 2312.14% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VPTDF wins by $38613850936.59M in total portfolio value
10 years
VPTDF
VPTDF
● Live price
2312.14%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38613850936.61M
Annual income
$35,586,201,922,515,856.00
Full VPTDF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — VPTDF vs JNJ

📍 VPTDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVPTDFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VPTDF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
VPTDF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VPTDF
Annual income on $10K today (after 15% tax)
$196,531.79/yr
After 10yr DRIP, annual income (after tax)
$30,248,271,634,138,476.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, VPTDF beats the other by $30,248,271,634,137,772.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VPTDF + JNJ for your $10,000?

VPTDF: 50%JNJ: 50%
100% JNJ50/50100% VPTDF
Portfolio after 10yr
$19306925468.32M
Annual income
$17,793,100,961,258,342.00/yr
Blended yield
92.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VPTDF
No analyst data
Altman Z
-272.5
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VPTDF buys
0
JNJ buys
0
No recent congressional trades found for VPTDF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVPTDFJNJ
Forward yield2312.14% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$38613850936.61M ✓$20.0K
Annual income after 10y$35,586,201,922,515,856.00 ✓$827.78
Total dividends collected$38401207511.77M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VPTDF vs JNJ ($10,000, DRIP)

YearVPTDF PortfolioVPTDF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$241,914$231,213.87$10,676$355.77+$231.2K → VPTDF
2$5,486,310$5,227,462.00$11,407$389.39+$5.47M → VPTDF
3$116,667,010$110,796,658.85$12,198$426.53+$116.65M → VPTDF
4$2,326,799,779$2,201,966,078.24$13,056$467.62+$2326.79M → VPTDF
5$43,532,552,320$41,042,876,556.38$13,987$513.12+$43532.54M → VPTDF
6$764,223,950,336$717,644,119,353.02$14,998$563.56+$764223.94M → VPTDF
7$12,591,932,032,884$11,774,212,406,024.32$16,098$619.52+$12591932.02M → VPTDF
8$194,782,556,253,371$181,309,188,978,186.10$17,295$681.69+$194782556.24M → VPTDF
9$2,829,578,517,848,077$2,621,161,182,656,969.50$18,599$750.82+$2829578517.83M → VPTDF
10$38,613,850,936,613,300$35,586,201,922,515,856.00$20,022$827.78+$38613850936.59M → VPTDF

VPTDF vs JNJ: Complete Analysis 2026

VPTDF — Stock

Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model of the heart chamber using echocardiograms and magnetic resonance imaging images; and obtain reproducible, accurate volumetric measurement, and ejection fraction. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is based in Toronto, Canada.

Full VPTDF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this VPTDF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VPTDF vs SCHDVPTDF vs JEPIVPTDF vs OVPTDF vs KOVPTDF vs MAINVPTDF vs ABBVVPTDF vs MRKVPTDF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.